Irish medical technology company eyeing 20 jobs to fuel UK expansion target
The Louth-based medical technology company behind the National Cardiac Device Registry is targeting a UK expansion and is expecting to create 20 jobs to support those ambitions.
Heart Rhythm Ireland
is rebranding as Heart Rhythm International (HRI) with the intention of developing business in the UK.
The medical technology company said it is expecting to add 30 additional hospitals and approximately 50,000 additional patients in the UK to its network before 2029, hoping for revenue growth of €3 million.
To fuel this expansion, HRI said it expects to grow its team to 30 people in the coming years, creating an additional 20 jobs.
READ MORE
'We're managing our expansion step by step, focusing initially on the UK market,' said Robert Kelly, the chief executive of HRI. The company is also targeting the Australian and New Zealand markets in the coming years with hopes of expanding into the US market too.
'We believe there is real opportunity for HRI to grow, to support more patients and doctors overseas, while helping advance cardiac care internationally in the years ahead,' he said.
100 days of Trump: 'It's like The Karate Kid, tax on, tax off, tariffs on, tariffs off'
Listen |
42:49
Through its work as the operator of the National Cardiac Device Registry, HRI works with more than 65,000 patients in Ireland with its platform being used by more than 50 cardiac hospitals in the country.
HRI operates a cloud-based cardiac rhythm management platform that makes patient cardiac information available in real time to patients and their medical teams.
The company, which was founded in 2008, said it is developing artificial intelligence and predictive analytics capabilities through its cardiac device management portal in the hopes of giving patients earlier insights.
[
New handheld device enables early detection of heart disease
Opens in new window
]
'Through our system, patients receive greater peace of mind and better health outcomes, while medical personnel can make better informed and more efficient decisions. Ultimately that improves patient care and helps save lives,' said Mr Kelly.
'We've already demonstrated how we can enhance cardiac care in Ireland by supporting over 65,000 patients and working with more than 50 hospitals nationwide. Now, we're bringing that capability overseas.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Times
5 hours ago
- Irish Times
The Irish Times view on the US/Iran talks: difficult compromises lie ahead
Many actors are in play and a great deal is at stake in the latest round of talks between the United States and Iran on that country's nuclear enrichment programme. Israel is threatening to attack Iranian nuclear plants if the US fails to act, European powers accuse Iran of breaching agreed inspections, while Gulf powers exert a powerful influence on President Donald Trump to avoid a dangerous war by compromises that would open up large economic opportunities for the US. These bilateral talks, and the parallel nuclear negotiations in Vienna, which could open up a new round of United Nations sanctions, hinge largely on whether Iran can continue its nuclear enrichment programme or must close it down. Iran flatly refuses to stop enrichment, a demand spearheaded by Israel and supported by a strong lobby within Trump's entourage. He has recently shifted his position towards no enrichment, but if that remains unacceptable to the Iranians he faces a fateful choice between finding a compromise and opening a path towards possible war. Trump's first overseas state visit to Saudi Arabia, the United Arab Emirates and Qatar last month exposed him to their immense wealth and newfound regional power, both of which he values. Their desire for more stable relations with Iran cuts right across Israeli leader Binyamin Netanyahu's push for military action against Iran's enrichment. That feeds into the intense debates around Trump's administration on whether such a war would derail his presidency. There is scope for diplomatic progress if the political will is there. One suggestion from the US negotiator Steve Witkoff is that Iran's enrichment for energy and other peaceful uses be tied into a wider regional programme that would create security and economic incentives all round. Iran's refusal of that option could shift if it sees UN sanctions as a real possibility and chooses to avoid that. France, Germany and the UK should channel such pressure towards finding such a path to regional security as part of their wider critique of Netanyahu's war in Gaza. READ MORE
RTÉ News
5 hours ago
- RTÉ News
Trump trade war - tariff deadlines & key upcoming events
The twists and turns in US President Donald Trump's tariff policies have not only rattled global financial markets but have also taken investors on a roller-coaster ride. Companies are counting the cost of the trade war that is now being estimated at more than $34 billion in lost sales and higher expenses, a Reuters analysis showed. Adding to the uncertainty are tariff-related legal challenges and Trump's assertion that he would hammer out bilateral deals with trade partners, even though agreements remain elusive, save a pact with Britain this month. Here's a timeline for key upcoming events and dates that could have a bearing on the US tariff policy: June 11, 2025 - Trump says US deal with China is done, with Beijing to supply magnets and rare earth minerals. A White House official said the agreement allows the US to charge a 55% tariff on imported Chinese goods, while China would charge a 10% tariff on US imports. The deal is subject to final approval from President Trump and Chinese President Xi Jinping. June 15-17 - Trump will attend the annual summit of G7 nations in Canada. The summit will be hosted at the Rocky Mountain resort town of Kananaskis, Alberta, with tariffs expected to be a major topic of discussion. July 8 - "Liberation Day" tariffs to take effect following the 90-day suspension period, potentially affecting imports from multiple countries.
RTÉ News
6 hours ago
- RTÉ News
AerCap can recover over $1 billion, UK court rules in case over jets 'lost' in Russia
The world's largest aircraft lessor AerCap can recover over $1 billion in relation to jets stuck in Russia since the invasion of Ukraine, London's High Court ruled today, though that is less than the roughly $2 billion it sought. The court ruled broadly in favour of leasing companies in a multi-billion-dollar legal dispute with insurers, following a mammoth trial of one of the biggest insurance disputes ever heard in London which concluded in February. The lawsuit had focused on almost 150 jets and some engines, previously with a total value of up to $4.7 billion, though settlements - including on the first day of the trial in October - have whittled the numbers down. Judge Christopher Butcher said in a summary of his ruling that the aircraft were lost and "that loss occurred on 10 March 2022, when a piece of Russian legislation banned the export of aircraft and aircraft equipment from Russia". That meant the lessors could recover from their "war risks insurers", rather than under a broader all risks clause, as the cause of the loss was "an act or order of the Russian government", Butcher said. The judge also ruled that insurers were not prevented by EU or US sanctions from indemnifying the claimants for the loss of aircraft which had been leased to Russian airlines. AerCap's law firm Herbert Smith Freehills Kramer said the judgment secured $1.035 billion for AerCap, "in addition to substantial recoveries achieved in prior settlements". The $1.035 billion sum is, however, less than AerCap's claimed losses of over $2 billion had it been able to recover under its all risks policy. Butcher said in his ruling that Dublin-based AerCap had received just over $1.3 billion from six settlements between August and December 2023 with lessees and a Russian insurance company. AerCap, Dubai Aerospace Enterprise (DAE), Merx Aviation, KDAC Aviation Finance, Falcon and Genesis had led the claims against a string of insurers, including AIG, Lloyd's, Chubb and Swiss Re. KDAC settled all its claims during the trial, Butcher said in his ruling, while AerCap, DAE and other lessors have periodically disclosed partial settlements.
